Venrock Adviser, LLC
CIK 1615982 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $3.3B
- Posisi
- 33
- Per tanggal
- 30 Juni 2026
#1.089 dari 9.443 berdasarkan nilai 13F · top 11.5%
Nilai portofolio QoQ: +23.1% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 80,39%
- Bobot 25 kepemilikan teratas
- 97,26%
- Posisi di atas 1%
- 19
- Jumlah posisi efektif
- 6,5
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 3,27% Perkiraan pembelian $97.716.203 · penjualan $368.894.281
Kepemilikan median: 4,0 kuartal Dilacak Q4 2024–Q2 2026 · 56,9% masih dipegang
- Posisi baru
- 4
- Meningkat
- 5
- Menurun
- 5
- Tertutup
- 4
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +107.2% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 95,9% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
98,6%
Lainnya/Tidak terpetakan
1,4%
Portofolio lengkap 33 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| APGE Apogee Therapeutics, Inc. - Common Stock | $1.127.318.496 | 34,18% | 8.493.321 | $412.435.667 | |||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $394.805.893 | 11,97% | 4.148.428 | $191.325.500 | |||
| ERAS Erasca, Inc. - Common Stock | $327.777.996 | 9,94% | 17.891.812 | $62.704.098 | Naik ×1 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $265.048.073 | 8,04% | 2.985.448 | $79.154.076 | Turun ×1 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $115.026.400 | 3,49% | 1.180.000 | $16.000.800 | |||
| OCUL Ocular Therapeutix, Inc. - Common Stock | $101.606.813 | 3,08% | 10.346.926 | $13.968.350 | |||
| GLTO Galecto, Inc. - Common Stock | $93.729.506 | 2,84% | 3.603.595 | $396.395 | |||
| SVRA Savara, Inc. - Common Stock | $90.835.009 | 2,75% | 14.745.943 | $15.812.561 | Naik ×1 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $71.556.488 | 2,17% | 3.220.364 | $26.310.374 | |||
| COGT Cogent Biosciences, Inc. - Common Stock | $63.551.824 | 1,93% | 1.642.166 | $-13.428.176 | Turun ×1 | ||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $59.847.935 | 1,81% | 3.257.917 | $-16.097.853 | Turun ×1 | ||
| VOR Vor Biopharma Inc. - Common Stock | $55.998.047 | 1,70% | 3.041.719 | $1.733.780 | |||
| DYN Dyne Therapeutics, Inc. - Common Stock | $48.282.608 | 1,46% | 2.173.913 | $8.869.565 | |||
| MAZE Maze Therapeutics, Inc. - Common Stock | $47.804.695 | 1,45% | 1.602.034 | $-16.020 | |||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $47.362.591 | 1,44% | 6.844.305 | $13.652.666 | Naik ×1 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $46.783.055 | 1,42% | 4.319.765 | $-7.948.368 | |||
| CBIO Crescent Biopharma, Inc. - Common Stock | $38.404.368 | 1,16% | 2.133.576 | $-789.423 | |||
| ZURA Zura Bio Limited - Class A Ordinary shares | $37.966.441 | 1,15% | 6.434.990 | $-321.750 | |||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $36.946.407 | 1,12% | 3.212.731 | $14.714.308 | |||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $26.711.298 | 0,81% | 526.331 | $-40.960.877 | Turun ×2 | ||
| HELP Cybin Inc. - Common Stock | $25.459.433 | 0,77% | 3.851.654 | $6.971.494 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $25.129.163 | 0,76% | 1.379.965 | $5.519.860 | |||
| IPSC Century Therapeutics, Inc. - Common Stock | $21.304.347 | 0,65% | 8.695.652 | $1.652.173 | |||
| ARTV Artiva Biotherapeutics, Inc. - Common Stock | $19.822.881 | 0,60% | 2.043.596 | $9.457.257 | Naik ×1 | ||
| CTMX CytomX Therapeutics, Inc. - Common Stock | $18.682.965 | 0,57% | 4.982.124 | $-28.233.018 | Turun ×2 | ||
| ACHV Achieve Life Sciences, Inc. - Common Shares | $17.964.239 | 0,54% | 2.751.032 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 698955101) | $17.106.250 | 0,52% | 625.000 | Naik ×1 | |||
| SRZN Surrozen, Inc. - Common Stock | $16.424.559 | 0,50% | 632.931 | $-2.012.721 | |||
| KRRO Korro Bio, Inc. - Common Stock | $13.305.210 | 0,40% | 1.009.500 | $1.877.670 | |||
| ANRO Alto Neuroscience, Inc. Common Stock | $13.195.000 | 0,40% | 500.000 | $1.955.000 | |||
| XFOR X4 Pharmaceuticals, Inc. - Common Stock | $9.032.962 | 0,27% | 1.934.253 | $7.667.894 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: G75226103) | $3.210.000 | 0,10% | 300.000 | Naik ×1 | |||
| INM InMed Pharmaceuticals Inc. - Common Shares | $50.662 | 0,00% | 32.685 | Naik ×1 | |||
| Tidak ada hasil | |||||||
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| APGE | Hanya pergerakan harga | +0 | +$412.4M |
| ORKA | Hanya pergerakan harga | +0 | +$191.3M |
| SYRE | Dipangkas | -700K | +$79.2M |
| ERAS | Beli lebih banyak | +1.5M | +$62.7M |
| ELVN | Dipangkas | -1.2M | -$41.0M |
| CTMX | Dipangkas | -5.0M | -$28.2M |
| JBIO | Hanya pergerakan harga | +0 | +$26.3M |
| VRDN | Dipangkas | -625K | -$16.1M |
| DNTH | Hanya pergerakan harga | +0 | +$16.0M |
| SVRA | Beli lebih banyak | +1.0M | +$15.8M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| MTSR | 31 Des. 2025 | 3.750.662 | $196.272.142 | Tidak lagi dilacak |
| KALV | 30 Juni 2026 | 6.474.485 | $130.331.383 | Tidak lagi dilacak |
| CDTX | 31 Des. 2025 | 946.788 | $90.664.419 | Tidak lagi dilacak |
| ABVX | 31 Des. 2025 | 576.729 | $48.964.292 | -12,8% |
| PRAX | 30 Juni 2025 | 989.985 | $37.490.732 | 801,3% |
| ENGN | 30 Juni 2026 | 4.771.414 | $32.493.329 | 4,3% |
| UPB | 31 Maret 2026 | 1.169.298 | $31.746.441 | -19,0% |
| TENX | 30 Juni 2026 | 1.675.262 | $26.787.439 | -87,6% |
| MRUS | 31 Maret 2025 | 592.411 | $24.910.883 | Tidak lagi dilacak |
| ATXS | 31 Des. 2025 | 2.457.348 | $17.889.493 | Tidak lagi dilacak |
| PHVS | 31 Des. 2025 | 674.599 | $16.831.245 | 31,6% |
| SEPN | 30 Juni 2026 | 506.056 | $12.160.526 | 29,1% |
| AQST | 31 Maret 2025 | 2.629.786 | $9.362.038 | 56,9% |
| SLDB | 30 Juni 2025 | 2.481.400 | $9.181.180 | 90,7% |
| PCSC | 31 Des. 2025 | 750.000 | $7.950.000 | Tidak lagi dilacak |
| TERN | 31 Maret 2025 | 1.077.090 | $5.967.079 | Tidak lagi dilacak |
| TSHA | 31 Maret 2025 | 3.225.180 | $5.579.561 | 338,8% |
| TRVI | 30 Juni 2025 | 615.506 | $3.871.533 | 241,3% |
| TENX | 31 Des. 2025 | 437.708 | $3.330.958 | -85,2% |
| APLT | 30 Juni 2025 | 5.567.709 | $2.722.053 | Tidak lagi dilacak |
| FDMT | 30 Juni 2025 | 677.600 | $2.188.648 | 323,3% |
| MRSN | 30 Juni 2025 | 3.574.325 | $1.230.283 | Tidak lagi dilacak |
| IPSC | 30 Juni 2025 | 2.498.069 | $1.189.081 | 272,1% |
| TNYA | 30 Juni 2025 | 1.555.556 | $886.822 | 17,6% |
| CASIF | 31 Maret 2026 | 987.259 | $839.170 | Tidak lagi dilacak |
| GLYC | 30 Juni 2025 | 3.000.000 | $630.000 | Tidak lagi dilacak |
| TIL | 30 Juni 2025 | 33.177 | $575.953 | -64,5% |